{"url_path":"/sec/ctso/8-k/2026-05-13/item-2-02","section_key":"item-2-02","section_title":"Item 2.02 Results of Operations and Financial Condition.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-13","source_url":"https://www.sec.gov/Archives/edgar/data/1175151/0000929638-26-001834-index.html","accession_number":"0000929638-26-001834","cik":"0001175151","ticker":"CTSO","issuer_name":"Cytosorbents Corp","edgar_url":"https://www.sec.gov/Archives/edgar/data/1175151/0000929638-26-001834-index.html","primary_entity_key":"0001175151","primary_entity_name":"Cytosorbents Corp"},"word_count":41,"has_tables":true,"body_markdown":"Item 2.02. Results of Operations and Financial Condition.\n\nOn May 13, 2026, CytoSorbents Corporation issued a press release announcing its financial results for the quarter ended March 31,\n2026. A copy of the press release is furnished herewith as Exhibit 99.1.*"}